Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to Section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the Cancer Advisory Panel for Complementary and Alternative Medicine (CAPCAM).

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

*Name of Committee:*                         Cancer Advisory Panel for Complementary and Alternative Medicine.                    

*Date:*                         May 21, 2001.                    

*Open:*                         May 21, 2001, 9:00 am to adjournment.                    

*Agenda:*                         The agenda will include a report on clinical trial data on Virulizen (R), an update on the Rand BSC Approach to BCS, an update on NIH initiatives for CAM and Cancer treatments, and other business of the Panel.                    

*Place:*                         Pooks Hill Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.                    

*Contact Person:*                         Richard Nahin, Ph.D., Executive Secretary, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Blvd, Suite 106, Bethesda, MD 20892, 301/496-7801.                    

The public comments session is scheduled on May 21 from 3:00 pm to 3:30 pm. Each speaker will be permitted 5 minutes for their presentation. Interested individuals and representatives of organizations are requested to notify Dr. Richard Nahin, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd, Suite 106, Bethesda, Maryland 20892, 301-496-7801, Fax 301-480-3621. Letters of intent to present comments, along with a brief description of the organization represented, should be received no later than 5:00 pm May 15, 2001. Only one representative of an organization may present oral comments. Any person attending the meeting who does not request an opportunity to speak in advance of the meeting may be considered for oral presentation, if time permits, and at the discretion of the Chairperson. In addition, written comments may be submitted to Dr. Nahin at the address listed above up to ten calendar days (May 31, 2001) following the meeting.

Copies of the meeting agenda and the roster of members will be furnished upon request by Dr. Richard Nahin, Executive Secretary, CAPCAM, National Institutes of Health, 6707 Democracy Blvd, Suite 106, Bethesda, Maryland 20892, 301 496-7801, Fax 301-480-3621.

This meeting is being published less than 15 days prior to the meeting due to scheduling conflicts.

Dated: May 9, 2001.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy, NIH.

[FR Doc. 01-12469 Filed 5-16-01; 8:45 am]

BILLING CODE 4140-01-M